We've already got commitments from 42 investment firms from 8 countries to attend BioTrinity 2010, including a number of corporate venture funds including the recently launched OSI Investment Holdings and a growing number of investment banks.  Last year, where we attracted nearly 40 investment firms by the time of the conference in April, so we are well on course to achieve our target of 100 delegates from 60-70 investment firms, among some 650 delegates.

Growing List of Investment Firms Already Confirmed as Participating:

  • Abingworth (Sponsor)
  • Advent Ventures
  • Aescap Venture Management BV (Netherlands)
  • Albion Ventures
  • Alta Partners (US)
  • Andy Richards
  • Atlas Venture
  • Beringea
  • BioGeneration Ventures (Netherlands)
  • ECI Partners
  • Edmond de Rothschild Investment Partners (France)
  • Entrepreneurs Fund
  • ETV Capital
  • Evolution Securities
  • Execution Noble
  • Forbion Capital Partners (Netherlands)
  • IP Group
  • IPSO Ventures
  • IQ Capital
  • KBC Peel Hunt
  • Kurma BioFund
  • MedImmune Ventures (US)
  • Mercia Fund Management
  • MVM Life Science Partners
  • Nomura Code Securities
  • Novo A/S
  • OSI Investment Holdings
  • Oxford Capital Partners
  • Oxford Technology Management
  • Paul Capital Partners
  • Piper Jaffray
  • Quest for Growth (Belgium)
  • Rainbow Seed Fund
  • Rosetta Capital
  • Scottish Equity Partners
  • Seroba Kernel (Ireland)
  • Singer Capital Markets
  • Sofinnova Partners (France)
  • SPARK Ventures
  • SR One
  • Takeda Research Investment (US)
  • Versant EuroVentures (Switzerland)

Key: VC, Corporate Venturer, Investment Bank, Angel

List of Investment Firms which Participated in 2009:

Abingworth Management
Advent Venture Partners
Albion Ventures LLP
Andy Richards (serial entrepreneur)
Atlas Venture
Beringea
Canaccord Adams
Edmond de Rothschild Investment Partners (France)
Entrepreneurs Fund
Esperante Ventures (Netherlands)
ETV Capital
Excalibur Group (formerly Merlin Biosciences)
Forbion Capital Partners (Netherlands)
Genzyme Ventures
H2O Venture Partners
IP Group plc
Ipso Ventures
IQ Capital
Mercia Technology Seed Fund
MVM Life Science Partners
New Hill Management
NESTA
NGN Capital
Nomura Code Securities
Novo Ventures (Denmark)
Orion Healthcare Equity Partners (USA)
Oxford Capital Partners
Oxford Technology Management
Piper Jaffray
Rainbow Seed Fund
Rosetta Capital
Seraphim Capital
Seroba Kernel (Ireland)
Seventure
Sofinnova Ventures (France)
SPARK Ventures
SR One (USA)
Takeda Research Investment Inc (USA)
The Wellcome Trust